Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice

Bone

Volumn 56, Issue 1, 2013, Pages 101-109

  Kuroshima, Shinichiro ^a   Yamashita, Junro ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Lymphangiogenesis; Melphalan; Osteonecrosis of the jaw; Wound healing; Zoledronic acid

Indexed keywords

DEXAMETHASONE; MELPHALAN; VASCULOTROPIN C; ZOLEDRONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; FLUORESCENCE ANALYSIS; IMMUNOHISTOCHEMISTRY; JAW OSTEONECROSIS; LYMPH NODE; LYMPHANGIOGENESIS; MACROPHAGE; MONOTHERAPY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSSIFICATION; TOOTH EXTRACTION; WOUND HEALING;

LYMPHANGIOGENESIS; MELPHALAN; OSTEONECROSIS OF THE JAW; WOUND HEALING; ZOLEDRONIC ACID;

ANIMALS; ANTINEOPLASTIC AGENTS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; IMIDAZOLES; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MELPHALAN; MICE; NEUTROPHILS; OSTEOCLASTS; TIBIA; TOOTH SOCKET; VASCULAR ENDOTHELIAL GROWTH FACTOR C; X-RAY MICROTOMOGRAPHY;

EID: 84879300625     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.05.013     Document Type: Article

References (51)

1. Khosla S., Burr D., Cauley J., Dempster D.W., Ebeling P.R., Felsenberg D., et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007, 22:1479-1491.
2. Herlofson B.B., Norman-Pedersen K., Redfors M., Fossa S.D. Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer. A retrospective study. Eur J Oral Sci 1997, 105:523-526.
3. Vardy J., Chiew K.S., Galica J., Pond G.R., Tannock I.F. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer 2006, 94:1011-1015.
4. O'Ryan F.S., Lo J.C. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg 2012, 70:1844-1853.
5. Hovi L., Saarinen U.M., Donner U., Lindqvist C. Opportunistic osteomyelitis in the jaws of children on immunosuppressive chemotherapy. J Pediatr Hematol Oncol 1996, 18:90-94.
6. Ruggiero S.L., Mehrotra B., Rosenberg T.J., Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004, 62:527-534.
7. Forner L., Larsen T., Kilian M., Holmstrup P. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006, 33:401-407.
8. Guntheroth W.G. How important are dental procedures as a cause of infective endocarditis?. Am J Cardiol 1984, 54:797-801.
9. Woo S.B., Sonis S.T., Monopoli M.M., Sonis A.L. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 1993, 72:1612-1617.
10. Heimdahl A., Mattsson T., Dahllof G., Lonnquist B., Ringden O. The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1989, 68:711-716.
11. Meyers J.D., Flournoy N., Thomas E.D. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant. J Infect Dis 1980, 142:338-346.
12. Aksu G., Ruhi M.Z., Akan H., Bengisun S., Ustun C., Arslan O., et al. Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 2001, 27:201-205.
13. Raber-Durlacher J.E., Epstein J.B., Raber J., van Dissel J.T., van Winkelhoff A.J., Guiot H.F., et al. Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 2002, 10:466-473.
14. Sung E.C., Chan S.M., Sakurai K., Chung E. Osteonecrosis of the maxilla as a complication to chemotherapy: a case report. Spec Care Dentist 2002, 22:142-146.
15. Lenz J.H., Steiner-Krammer B., Schmidt W., Fietkau R., Mueller P.C., Gundlach K.K. Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?. J Craniomaxillofac Surg 2005, 33:395-403.
16. Schwartz H.C. Osteonecrosis of the jaws: a complication of cancer chemotherapy. Head Neck Surg 1982, 4:251-253.
17. Wang J., Goodger N.M., Pogrel M.A. Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 2003, 61:1104-1107.
18. Kataru R.P., Jung K., Jang C., Yang H., Schwendener R.A., Baik J.E., et al. Critical role of CD11b+macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009, 113:5650-5659.
19. Ji R.C. Characteristics of lymphatic endothelial cells in physiological and pathological conditions. Histol Histopathol 2005, 20:155-175.
20. Cueni L.N., Detmar M. The lymphatic system in health and disease. Lymphat Res Biol 2008, 6:109-122.
21. Marchetti C., Poggi P. Lymphatic vessels in the oral cavity: different structures for the same function. Microsc Res Tech 2002, 56:42-49.
22. Okabe K., Nakagawa K., Yamamoto E. Factors affecting the occurrence of bacteremia associated with tooth extraction. Int J Oral Maxillofac Surg 1995, 24:239-242.
23. McMillan M.D. Neutrophils in the molar tooth extraction wound in the rat: a transmission electron microscope (TEM) study. J Oral Pathol Med 1999, 28:297-302.
24. Smith N. A comparative histological and radiographic study of extraction socket healing in the rat. Aust Dent J 1974, 19:250-254.
25. Baluk P., Tammela T., Ator E., Lyubynska N., Achen M.G., Hicklin D.J., et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005, 115:247-257.
26. Yamashita J., Datta N.S., Chun Y.H., Yang D.Y., Carey A.A., Kreider J.M., et al. Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone. J Bone Miner Res 2008, 23:621-632.
27. Yamashita J., Koi K., Yang D.Y., McCauley L.K. Effect of zoledronate on oral wound healing in rats. Clin Cancer Res 2011, 17:1405-1414.
28. Hokugo A., Sun S., Park S., McKenna C.E., Nishimura I. Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats. Bone 2013, 53:59-68.
29. Falco P., Bringhen S., Avonto I., Gay F., Morabito F., Boccadoro M., et al. Melphalan and its role in the management of patients with multiple myeloma. Expert Rev Anticancer Ther 2007, 7:945-957.
30. Pietrokovski J., Massler M. Residual ridge remodeling after tooth extraction in monkeys. J Prosthet Dent 1971, 26:119-129.
31. Iizuka T., Miller S.C., Marks S.C. Alveolar bone remodeling after tooth extraction in normal and osteopetrotic (ia) rats. J Oral Pathol Med 1992, 21:150-155.
32. Reinholt F.P., Hultenby K., Heinegard D., Marks S.C., Norgard M., Anderson G. Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia/ia) rats: implications for secretory function. Exp Cell Res 1999, 251:477-491.
33. Tabrizi R., Arabi A.M., Arabion H.R., Gholami M. Jaw osteomyelitis as a complication in osteopetrosis. J Craniofac Surg 2010, 21:136-141.
34. Bi Y., Gao Y., Ehirchiou D., Cao C., Kikuiri T., Le A., et al. Bisphosphonates cause osteonecrosis of the jaw-like disease in mice. Am J Pathol 2010, 177:280-290.
35. Li D., Gromov K., Proulx S.T., Xie C., Li J., Crane D.P., et al. Effects of antiresorptive agents on osteomyelitis: novel insights into the pathogenesis of osteonecrosis of the jaw. Ann N Y Acad Sci 2010, 1192:84-94.
36. Zhang Q., Guo R., Lu Y., Zhao L., Zhou Q., Schwarz E.M., et al. VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. J Biol Chem 2008, 283:13491-13499.
37. Zhang Q., Lu Y., Proulx S.T., Guo R., Yao Z., Schwarz E.M., et al. Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Arthritis Res Ther 2007, 9:R118.
38. Maruyama K., Asai J., Ii M., Thorne T., Losordo D.W., D'Amore P.A. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007, 170:1178-1191.
39. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003, 61:1115-1117.
40. Francini F., Pascucci A., Francini E., Miano S.T., Bargagli G., Ruggiero G., et al. Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab. J Am Dent Assoc 2011, 142:506-513.
41. Guarneri V., Miles D., Robert N., Dieras V., Glaspy J., Smith I., et al. Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer. Breast Cancer Res Treat 2010, 122:181-188.
42. Kuroshima S., Go V.A., Yamashita J. Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice. Endocrinology 2011, 153:17-28.
43. Radden H.G. Local factors in healing of the alveolar tissues. Ann R Coll Surg Engl 1959, 24:366-386.
44. Amler M.H., Johnson P.L., Salman I. Histological and histochemical investigation of human alveolar socket healing in undisturbed extraction wounds. J Am Dent Assoc 1960, 61:32-44.
45. Kikuiri T., Kim I., Yamaza T., Akiyama K., Zhang Q., Li Y., et al. Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 2010, 25:1668-1679.
46. Brubaker K.D., Brown L.G., Vessella R.L., Corey E. Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment. BMC Cancer 2006, 6:15.
47. Odri G.A., Dumoucel S., Picarda G., Battaglia S., Lamoureux F., Corradini N., et al. Zoledronic acid as a new adjuvant therapeutic strategy for Ewing's sarcoma patients. Cancer Res 2010, 70:7610-7619.
48. Gohel A., McCarthy M.B., Gronowicz G. Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 1999, 140:5339-5347.
49. Postnov A., De Schutter T., Sijbers J., Karperien M., De Clerck N. Glucocorticoid-induced osteoporosis in growing mice is not prevented by simultaneous intermittent PTH treatment. Calcif Tissue Int 2009, 85:530-537.
50. Aghaloo T.L., Kang B., Sung E.C., Shoff M., Ronconi M., Gotcher J.E., et al. Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat. J Bone Miner Res 2011, 26:1871-1882.
51. Mawardi H., Giro G., Kajiya M., Ohta K., Almazrooa S., Alshwaimi E., et al. A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw. J Dent Res 2011, 90:1339-1345.